These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 238144)

  • 41. Involvement of the brain catecholaminergic system in the regulation of dominant behavior.
    Serova LI; Naumenko EV
    Pharmacol Biochem Behav; 1996 Feb; 53(2):285-90. PubMed ID: 8808133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The catecholaminergic system of the quail brain: immunocytochemical studies of dopamine beta-hydroxylase and tyrosine hydroxylase.
    Bailhache T; Balthazart J
    J Comp Neurol; 1993 Mar; 329(2):230-56. PubMed ID: 8095939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of acute and chronic gonadectomy on the catecholamine innervation of the cerebral cortex in adult male rats: insensitivity of axons immunoreactive for dopamine-beta-hydroxylase to gonadal steroids, and differential sensitivity of axons immunoreactive for tyrosine hydroxylase to ovarian and testicular hormones.
    Kritzer MF
    J Comp Neurol; 2000 Nov; 427(4):617-33. PubMed ID: 11056468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uraemia suppresses central dopaminergic metabolism and impairs motor activity in rats.
    Adachi N; Lei B; Deshpande G; Seyfried FJ; Shimizu I; Nagaro T; Arai T
    Intensive Care Med; 2001 Oct; 27(10):1655-60. PubMed ID: 11685308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of DOPA on the visual-evoked potentials in rabbit and on mouse motor behavior following inhibition of dopamine-beta-hydroxylase.
    Sabelli HC; Giardina WJ; Myles SB; Vazquez AJ
    Arzneimittelforschung; 1974 Mar; 24(3):333-7. PubMed ID: 4407412
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of two inhibitors of dopamine beta-hydroxylase on maturation of memory in mice.
    Flexner JB; Flexner LB
    Pharmacol Biochem Behav; 1976 Aug; 5(2):117-21. PubMed ID: 996046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postnatal elevation of brain tyrosine hydroxylase activity, without concurrent increases in steady-state catecholamine levels, resulting from dl-alpha-methylparatyrosine administration during embryonic development.
    Lydiard RB; Fossom LH; Sparber SB
    J Pharmacol Exp Ther; 1975 Jul; 194(1):27-36. PubMed ID: 239220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Environmental light conditions alter gene expression of rat catecholamine biosynthetic enzymes and Neuropeptide Y: differential effect in superior cervical ganglia and adrenal gland.
    Gallara RV; Bellavia SL; Serova LL; Sabban EL
    Brain Res Mol Brain Res; 2004 May; 124(2):152-8. PubMed ID: 15135223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential inhibitors of tyrosine hydroxylase and dopamine-beta-hydroxylase.
    Scott KR; Alt CJ; Kemp M; Hayes E; Telang VG
    J Pharm Sci; 1984 Nov; 73(11):1531-5. PubMed ID: 6151595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 51. Strain-dependency in motor activity and in concentration and turnover of catecholamines in synchronized rats.
    Lemmer B; Caspari-Irving G; Weimer R
    Pharmacol Biochem Behav; 1981 Aug; 15(2):173-8. PubMed ID: 6118882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on memory: the cerebral spread of an engram in mice as affected by inhibitors of dopamine beta-hydroxylase.
    Flexner JB; Flexner LB; Church AC
    Pharmacol Biochem Behav; 1983 Apr; 18(4):519-23. PubMed ID: 6867057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrosine hydroxylase and dopamine beta-hydroxylase inhibiting properties of a new series of pyridazinyl hydrazones.
    Huszti Z; Szilágyi G; Kasztreiner E
    Biochem Pharmacol; 1983 Feb; 32(4):627-36. PubMed ID: 6131675
    [No Abstract]   [Full Text] [Related]  

  • 54. Dopamine-beta-hydroxylase inhibitors, feeding and locomotor activity: reinstatement of feeding following central norepinephrine.
    Evans KR; Beninger RJ; Eikelboom R
    Pharmacol Biochem Behav; 1985 Apr; 22(4):535-40. PubMed ID: 3991764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The anticonvulsant action of methazolamide in mice: antagonism by various inhibitors of dopamine beta-hydroxylase.
    Lotti VJ; Torchiana ML; Stone CA
    Eur J Pharmacol; 1977 Aug; 44(4):387-90. PubMed ID: 19268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Norepinephrine-dopamine interactions and behavior.
    Antelman SM; Caggiula AR
    Science; 1977 Feb; 195(4279):646-53. PubMed ID: 841304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in the content and turnover of noradrenaline in rat heart atria and ventricles and circadian-phase-dependency.
    Lemmer B; Weimer R
    Experientia; 1983 Sep; 39(9):998-1000. PubMed ID: 6884497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diurnal rhythm in the central dopamine turnover in the rat.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):257-61. PubMed ID: 567283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proceedings: Reduction of locomotor activity in mice by dopamine-beta-hydroxylase inhibitors--evidence against the involvement of non-specific irritation.
    Dolphin AC; Elliott PN; Jenner P
    Br J Pharmacol; 1976 Mar; 56(3):395P. PubMed ID: 1260217
    [No Abstract]   [Full Text] [Related]  

  • 60. Cardiovascular effects of L-tyrosine: influence of blockade of tyrosine metabolism.
    Ekholm S; Karppanen H
    Eur J Pharmacol; 1989 Apr; 163(2-3):209-17. PubMed ID: 2566501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.